The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Trinucleotide repeat length instability and age of onset in Huntington's disease
Abstract
The initial observation of an expanded and unstable trinucleotide repeat in the Huntington's disease gene has now been confirmed and extended in 150 independent Huntington's disease families. HD chromosomes contained 37-86 repeat units, whereas normal chromosomes displayed 11-34 repeats. The HD repeat length was inversely correlated with the age of onset of the disorder. The HD repeat was unstable in more than 80% of meiotic transmissions showing both increases and decreases in size with the largest increases occurring in paternal transmissions. The targeting of spermatogenesis as a particular source of repeat instability is reflected in the repeat distribution of HD sperm DNA. The analysis of the length and instability of individual repeats in members of these families has profound implications for presymptomatic diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the unaffected population ranges on average 16-20 triplet repeats at this locus, affected patients contain 5 40 CAGs, with the age of symptom onset in general inversely correlating with repeat length (Duyao et al. , 1993; Labbadia and Morimoto, 2013).”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as Duyao et al., 1993
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Self-citationAndrogen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Self-citationFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453
Research works printed but not linked: 1
- SAS/STAT User's Guide, Version 6, 4th edn, Vol.2 (SAS Institute Inc., Cary, North Carolina, 1989).
Cited by
Sorted by citations
Items 201–300 of 998
Huntington disease expansion mutations in humans can occur before meiosis is completed
Yoon, S., Dubeau, L., de Young, M., Wexler, N. S., & Arnheim, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1331390100 · Cited by 104
Self-citationFamilial influence on age of onset among siblings with Huntington disease
Rosenblatt, A., Brinkman, R. R., Liang, K., Almqvist, E. W., Margolis, R. L., Huang, C., Sherr, M., Franz, M. L., Abbott, M. H., Hayden, M. R., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1400 · Cited by 103
Self-citationHuntington disease without CAG expansion: phenocopies or errors in assignment?
Andrew, S. E., Goldberg, Y. P., Kremer, B. P. H., Squitieri, F., Theilmann, J., Zeisler, J., Telenius, H., Adam, S., Almquist, E., & Anvret, M. (1994) · PubMed Central · Cited by 103
Yu-Taeger, L., Petrasch‐Parwez, E., Osmand, A. P., Redensek, A., Metzger, S., Clemens, L. E., Park, L., Howland, D., Calaminus, C., Gu, X., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1148-12.2012 · Cited by 114
Bêcher, M. W., Rubinsztein, D. C., Leggo, J., Wagster, M. V., Stine, O. C., Ranen, N. G., Franz, M. L., Abbott, M. H., Sherr, M., MacMillan, J., et al. (1997) · Movement Disorders · doi:10.1002/mds.870120408 · Cited by 102
Self-citationHuntington's disease–like 2 (HDL2) in North America and Japan
Margolis, R. L., Holmes, S. E., Rosenblatt, A., Gourley, L. M., O’Hearn, E., Ross, C. A., Seltzer, W. K., Walker, R. H., Ashizawa, T., Rasmussen, A., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20248 · Cited by 102
Self-citationLeeflang, E. P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.173 · Cited by 104
Dorsey, E. R., & the Huntington Study Group COHORT Investigators (2012) · PLoS ONE · doi:10.1371/journal.pone.0029522 · Cited by 101
Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA)
Ross, C. A., Margolis, R. L., Rosenblatt, A., Ranen, N. G., Bêcher, M. W., & Aylward, E. (1997) · Medicine · doi:10.1097/00005792-199709000-00001 · Cited by 101
Self-citationStriatal Volume Contributes to the Prediction of Onset of Huntington Disease in Incident Cases
Aylward, E., Liu, D., Nopoulos, P., Ross, C. A., Pierson, R. K., Mills, J. A., Long, J. D., & Paulsen, J. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.030 · Cited by 100
Self-citationTrinucleotide repeat length and rate of progression of Huntington's disease
Illarioshkin, S. N., Igarashi, S., Onodera, O., Markova, E. D., Nikolskaya, N. N., Tanaka, H., Tz, C., Insarova, N. G., Endo, K., Ivanova‐Smolenskaya, I. A., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360412 · Cited by 99
GAA repeat instability in Friedreich ataxia YAC transgenic mice
Al‐Mahdawi, S., Pinto, R. M., Ruddle, P., Carroll, C. J., Webster, Z., & Pook, M. A. (2004) · Genomics · doi:10.1016/j.ygeno.2004.04.003 · Cited by 99
Simple is good: yeast models of neurodegeneration
Tenreiro, S., & Outeiro, T. F. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00649.x · Cited by 102
Li, Y., Chin, L., Levey, A. I., & Li, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111612200 · Cited by 98
Characterization of the Huntington's disease (HD) gene homolog in the zebrafish Danio rerio
Karlovich, C., John, R. M., Ramirez, L., Stainier, D. Y. R., & Myers, R. (1998) · Gene · doi:10.1016/s0378-1119(98)00342-4 · Cited by 97
Self-citationOʼKusky, J. R., Nasir, J., Cicchetti, F., Parent, A., & Hayden, M. R. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01312-2 · Cited by 97
Managing Juvenile Huntington’s Disease
Quarrell, O., NANCE, M. A., Nopoulos, P., Paulsen, J. S., Smith, J. A., & Squitieri, F. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.18 · Cited by 96
Huntingtin interacts with cystathionine beta-synthase
Boutell, J. M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.371 · Cited by 95
Beyond muscles: The untapped potential of creatine
Riesberg, L. A., Weed, S. A., McDonald, T. L., Eckerson, J. M., & Drescher, K. M. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.034 · Cited by 95
Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS
Killoran, A., Biglan, K., Jankovic, J. J., Eberly, S. W., Kayson, E., Oakes, D., Young, A. B., & Shoulson, I. (2013) · Neurology · doi:10.1212/wnl.0b013e318294b304 · Cited by 104
Self-citationTrinucleotide Repeat Expansion and Neuropsychiatric Disease
Margolis, R. L., McInnis, M. G., Rosenblatt, A., & Ross, C. A. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1019 · Cited by 95
Self-citationBrain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation
Reynolds, G. P., Dalton, C., Tillery, C. E., Mangiarini, L., Davies, S. W., & Bates, G. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721773.x · Cited by 95
Igarashi, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.923 · Cited by 95
Bilney, B., Morris, M. E., & Perry, A. R. (2003) · Neurorehabilitation and neural repair · doi:10.1177/0888439002250448 · Cited by 100
Strehlow, A. N. T., Li, J. Z., & Myers, R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl467 · Cited by 93
Self-citationGusella, J. F., & MacDonald, M. E. (1995) · Seminars in Cell Biology · doi:10.1016/1043-4682(95)90011-x · Cited by 93
Self-citationAnticipation in Swedish families with bipolar affective disorder.
Nylander, P.-O., Engström, C., Chotai, J., Wahlström, J., & Adolfsson, R. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.9.686 · Cited by 93
Destabilization of CAG Trinucleotide Repeat Tracts by Mismatch Repair Mutations in Yeast
Schweitzer, J. K., & Livingston, D. M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.3.349 · Cited by 96
Lloret, A., Dragileva, E., Teed, A. M., Espinola, J. A., Fossale, E., Gillis, T., Lopez, E., Myers, R. H., MacDonald, M. E., & Wheeler, V. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl125 · Cited by 92
Self-citationSoyal, S. M., Felder, T. K., Auer, S., Hahne, P., Oberkofler, H., Witting, A., Paulmichl, M., Landwehrmeyer, G. B., Weydt, P., Patsch, W., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds177 · Cited by 93
Early detection of Huntington‘s disease
Paulsen, J. S. (2009) · Future Neurology · doi:10.2217/fnl.09.78 · Cited by 93
McAllister, B., Donaldson, J., Binda, C. S., Powell, S., Chughtai, U., Edwards, G., Stone, J., Lobanov, S. V., Elliston, L., Schuhmacher, L.-N., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01033-5 · Cited by 84
Self-citationHuntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease
Metzger, S., Rong, J., Nguyen, H. P., Cape, A., Tomiuk, J., Soehn, A. S., Propping, P., Freudenberg-Hua, Y., Freudenberg, J., Tong, L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn003 · Cited by 91
Dentatorubral–pallidoluysian atrophy
Tsuji, S. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-51892-7.00041-3 · Cited by 88
Kovalenko, M. V., Dragileva, E., Claire, J. S., Gillis, T., Guide, J. R., New, J., Dong, H., Kucherlapati, R., Kucherlapati, M. H., Ehrlich, M. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044273 · Cited by 88
Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models
Wheeler, V. C., & Dion, V. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-200426 · Cited by 88
Andresen, J. M., Gayán, J., Cherny, S. S., Brocklebank, D., Alkorta‐Aranburu, G., Addis, E. A., Cardon, L. R., Housman, D. E., & Wexler, N. S. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045153 · Cited by 87
Self-citationPGC-1alphaas modifier of onset age in Huntington disease
Taherzadeh-Fard, E., Saft, C., Andrich, J., Wieczorek, S., & Arning, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-10 · Cited by 109
Poly-l-Glutamine Forms Cation Channels: Relevance to the Pathogenesis of the Polyglutamine Diseases
Monoi, H., Futaki, S., Kugimiya, S., Minakata, H., & Yoshihara, K. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76830-5 · Cited by 86
Loupe, J. M., Pinto, R. M., Kim, K., Gillis, T., Mysore, J. S., Andrew, M. A., Kovalenko, M. V., Murtha, R., Seong, I., Gusella, J. F., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa196 · Cited by 85
Self-citationSquitieri, F., Berardelli, A., Nargi, E., Castellotti, B., Mariotti, C., Cannella, M., Lavitrano, M., de Grazia, U., Gellera, C., & Ruggieri, S. A. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580108.x · Cited by 85
Human MutLγ, the MLH1–MLH3 heterodimer, is an endonuclease that promotes DNA expansion
Kadyrova, L. Y., Gujar, V. V., Burdett, V., Modrich, P. L., & Kadyrov, F. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914718117 · Cited by 82
SCA2 trinucleotide expansion in German SCA patients
Rieß, O., Laccone, F. A., Gispert, S., Schöls, L. J., Zühlke, C., Vieira-Saecker, A. M. M., Herlt, S., Wessel, K., Epplen, J. T., Weber, B. H. F., et al. (1997) · Neurogenetics · doi:10.1007/s100480050009 · Cited by 84
Lee, J., Pinto, R. M., Gillis, T., Claire, J. S., & Wheeler, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023647 · Cited by 87
Rosas, H. D., Feigin, A., & Hersch, S. M. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.2.263 · Cited by 84
Refining the diagnosis of Huntington disease: the PREDICT-HD study
Biglan, K. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00012 · Cited by 83
Dubourg, O., Dürr, A., Cancel‐Tassin, G., Stévanin, G., Penet, C., Agid, Y., Brice, A., & Chneiweiss, H. (1995) · Annals of Neurology · doi:10.1002/ana.410370207 · Cited by 83
Trinucleotide Repeat Instability: Genetic Features and Molecular Mechanisms
Spada, A. R. L. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00895.x · Cited by 83
Budworth, H., Harris, F. R., Williams, P. T., Lee, D. Y., Holt, A., Pahnke, J., Szczęsny, B., Acevedo‐Torres, K., Ayala‐Peña, S., & McMurray, C. T. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005267 · Cited by 83
Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17
Gao, R., Matsuura, T., Coolbaugh-Murphy, M. I., Zühlke, C., Nakamura, K., Rasmussen, A., Siciliano, M. J., Ashizawa, T., & Lin, X. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201954 · Cited by 82
Ross, C. A., Wood, J., Schilling, G., Peters, M. F., Nucifora, F. C., Cooper, J. K., Sharp, A. H., Margolis, R. L., & Borchelt, D. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0452 · Cited by 82
Self-citationGiordani, B., Berent, S., Boivin, M. J., Penney, J. B., Lehtinen, S., Markel, D. S., Hollingsworth, Z. R., Butterbaugh, G. J., Hichwa, R. D., Gusella, J. F., et al. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250063014 · Cited by 82
Self-citationChapter 33 The history of movement disorders
Lanska, D. J. (2009) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)02133-7 · Cited by 83
Relevance of biomarkers across different neurodegenerative diseases
Ehrenberg, A. J., Khatun, A., Coomans, E. M., Betts, M. J., Capraro, F., Thijssen, E. H., Senkevich, K. A., Bharucha, T., Jafarpour, M., Young, P. N. E., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00601-w · Cited by 81
Artificial miRNAs as therapeutic tools: Challenges and opportunities
Kotowska‐Zimmer, A., Pewińska, M., & Olejniczak, M. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1640 · Cited by 82
The role of long non-coding RNAs in the pathogenesis of hereditary diseases
Sparber, P. A., Filatova, A. Y., Khantemirova, M., & Skoblov, M. Y. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0487-6 · Cited by 81
Onodera, O., Oyake, M., Takano, H., Ikeuchi, T., Igarashi, S., & Tsuji, S. (1995) · Europe PMC (PubMed Central) · Cited by 80
Schöls, L. J., Amoiridis, G., Epplen, J. T., Langkafel, M., Przuntek, H., & Rieß, O. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.5.466 · Cited by 80
Li, J., Hayden, M. R., Warby, S. C., Dürr, A., Morrison, P. J., NANCE, M. A., Ross, C. A., Margolis, R. L., Rosenblatt, A., Squitieri, F., et al. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-71 · Cited by 79
Self-citationHigh Germinal Instability of the (CTG)n at the SCA8 Locus of Both Expanded and Normal Alleles
Silveira, I., Alonso, I. D. C. M. P., Guimarães, L., Mendonça, P., Santos, C., Maciel, P., de Matos, J. M. F., Costa, M., Barbot, C., Tuna, A., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302827 · Cited by 79
Susceptibility Genes and the Question of Embodied Identity
Lock, M. M., Freeman, J., Chilibeck, G., Beveridge, B., & Padolsky, M. (2007) · Medical Anthropology Quarterly · doi:10.1525/maq.2007.21.3.256 · Cited by 78
Ruskin, D. N., Ross, J. L., Kawamura, M., Ruiz, T., Geiger, J. D., & Masino, S. A. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.001 · Cited by 78
Coenzyme Q treatment of neurodegenerative diseases of aging
Galpern, W. R., & Cudkowicz, M. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.01.004 · Cited by 78
Correlations Between Triplet Repeat Expansion and Clinical Features in Huntington's Disease
Claes, S. J., Zand, K. V., Legius, E., Dom, R., Malfroid, M., Baro, F., Godderis, J., & Cassiman, J. J. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540320021009 · Cited by 77
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16
Djouss�, L., Knowlton, B. A., Hayden, M. R., Brinkman, R. R., Ross, C. A., Margolis, R. L., Rosenblatt, A., Dürr, A., Dodé, C., Morrison, P. J., et al. (2004) · Neurogenetics · doi:10.1007/s10048-004-0175-2 · Cited by 77
Self-citationCaenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
Roussos, A., Kitopoulou, K., Borbolis, F., & Palikaras, K. (2023) · Biomolecules · doi:10.3390/biom13030478 · Cited by 82
The Ubiquitin-Proteasome Pathway in Huntington's Disease
Mitra, S. S., & Finkbeiner, S. M. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.60 · Cited by 76
Huntington's disease in the United States: Variation by demographic and socioeconomic factors
Bruzelius, E., Scarpa, J. R., Zhao, Y., Basu, S., Faghmous, J. H., & Baum, A. (2019) · Movement Disorders · doi:10.1002/mds.27653 · Cited by 76
Michele, G. D., Cavalcanti, F., Criscuolo, C., Pianese, L., Monticelli, A., Filla, A., & Cocozza, S. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.12.1901 · Cited by 82
Molecular Pathogenesis in Huntington’s Disease
Illarioshkin, S. N., Klyushnikov, S. A., Vigont, V. A., Seliverstov, Y. A., & Kaznacheyeva, E. V. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090043 · Cited by 79
Striking changes in anxiety in Huntington's disease transgenic mice
File, S. E., Mahal, A., Mangiarini, L., & Bates, G. P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00736-7 · Cited by 75
Experience over fifteen years with a protocol for predictive testing for Huntington disease
Dufrasne, S., Roy, M., Gálvez, M. C. C., & Rosenblatt, D. S. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.12.001 · Cited by 75
Møllersen, L., Rowe, A. D., Illuzzi, J. L., Hildrestrand, G. A., Gerhold, K. J., Tveterås, L., Bjølgerud, A., Wilson, D. M., Bjørås, M., & Klungland, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds337 · Cited by 74
HD CAG-correlated gene expression changes support a simple dominant gain of function
Jacobsen, J. C., Gregory, G. C., Woda, J. M., Thompson, M. N., Coser, K. R., Murthy, V., Kohane, I. S., Gusella, J. F., Seong, I. S., MacDonald, M. E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr195 · Cited by 74
Self-citationSequeiros, J., Ramos, E. M., Cerqueira, J., Costa, M., Sousa, A., Pinto‐Basto, J., & Alonso, I. D. C. M. P. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01388.x · Cited by 74
DNA methylation profiling in human Huntington's disease brain
Souza, R. A. G. D., Islam, S. A., McEwen, L. M., Mathelier, A., Hill, A. M., Mah, S. M., Wasserman, W. W., Kobor, M. S., & Leavitt, B. R. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw076 · Cited by 75
Ishiguro, H., Yamada, K., Sawada, H., Nishii, K., Ichino, N., Sawada, M., Kurosawa, Y., Matsushita, N., Kobayashi, K., Goto, J., et al. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1153 · Cited by 74
Warner, T. T., Williams, L. D., Walker, R. W. H., Flinter, F. A., Robb, S. A., Bundey, S., Honavar, M., & Harding, A. E. (1995) · Annals of Neurology · doi:10.1002/ana.410370407 · Cited by 74
Reddy, P. H., Charles, V., Williams, M., Miller, G., Whetsell, W. O., & Tagle, D. A. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0456 · Cited by 73
Triplet repeats in transcripts: structural insights into RNA toxicity
Galka-Marciniak, P., Urbanek-Trzeciak, M. O., & Krzyżosiak, W. J. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0218 · Cited by 75
Monckton, D. G. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-200429 · Cited by 72
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer
Gazouli, M., Tzanakis, Ν., Rallis, G., Theodoropoulos, G. E., Papaconstantinou, I. G., Kostakis, A. G., Anagnou, N. P., & Nikiteas, N. I. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0601-2 · Cited by 72
Transgenic Mice in the Study of Polyglutamine Repeat Expansion Diseases
Bates, G. P., Mangiarini, L., & Davies, S. W. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00196.x · Cited by 72
Toward Understanding the Molecular Pathology of Huntington's Disease
Wellington, C. L., Brinkman, R. R., OʼKusky, J. R., & Hayden, M. R. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00897.x · Cited by 71
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
Takeuchi, T., & Nagai, Y. (2017) · Brain Sciences · doi:10.3390/brainsci7100128 · Cited by 71
Genetics of Huntington disease
NANCE, M. A. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801893-4.00001-8 · Cited by 71
Transcription Elongation and Tissue-Specific Somatic CAG Instability
Goula, A.-V., Styś, A., Chan, J. P. K., Trottier, Y., Festenstein, R., & Mérienne, K. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003051 · Cited by 71
Kim, K., Hong, E. P., Shin, J. W., Chao, M. J., Loupe, J. M., Gillis, T., Mysore, J. S., Holmans, P., Jones, L., Orth, M., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.05.012 · Cited by 70
Self-citationCancer incidence in patients with polyglutamine diseases: a population-based study in Sweden
Ji, J., Sundquist, K., & Sundquist, J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70132-8 · Cited by 71
Mouse Huntington's disease gene homolog (Hdh)
Barnes, G. T., Duyao, M. P., Ambrose, C. M., McNeil, S. M., Persichetti, F., Srinidhi, J., Gusella, J. F., & MacDonald, M. E. (1994) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02290678 · Cited by 70
Self-citationAntibodies and protein misfolding: From structural research tools to therapeutic strategies
Genst, E. D., Messer, A. C., & Dobson, C. M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.08.016 · Cited by 70
The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration
Leegwater‐Kim, J., & Cha, J.-H. J. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.128 · Cited by 68
Self-citationContinuous and Periodic Expansion of CAG Repeats in Huntington's Disease R6/1 Mice
Møllersen, L., Rowe, A. D., Larsen, E., Rognes, T., & Klungland, A. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001242 · Cited by 71
Chromosomal instability during neurogenesis in Huntington's disease
Ruzo, A., Croft, G. F., Metzger, J. J., Galgoczi, S., Gerber, L. J., Pellegrini, C., Wang, H., Fenner, M., Tse, S., Marks, A. R., et al. (2018) · Development · doi:10.1242/dev.156844 · Cited by 69
Kay, C., Collins, J. A., Wright, G. E. B., Baine, F., Miedzybrodzka, Z., Aminkeng, F., Semaka, A., McDonald, C. L., Davidson, M., Madore, S. J., et al. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32618 · Cited by 69
Radulescu, C. I., Garcia‐Miralles, M., Sidik, H., Bardile, C. F., Yusof, N. A. B. M., Lee, H. U., Ho, E. X. P., Chu, C. W., Layton, E., Low, D., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.011 · Cited by 68
Kovtun, I. V. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2767 · Cited by 69
Common SNP-Based Haplotype Analysis of the 4p16.3 Huntington Disease Gene Region
Lee, J., Gillis, T., Mysore, J. S., Ramos, E. M., Myers, R. H., Hayden, M. R., Morrison, P. J., Nance, M., Ross, C. A., Margolis, R. L., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.01.005 · Cited by 68
Self-citationProtein misfolding inside cells: The case of huntingtin and Huntington's disease
Hatters, D. M. (2008) · IUBMB Life · doi:10.1002/iub.111 · Cited by 70
Somatic expansion of the (CAG) n repeat in Huntington disease brains
de Rooij, K. E., Gans, P. A. M. D. K., Roos, R. A. C., van Ommen, G. B., & den Dunnen, J. T. (1995) · Human Genetics · doi:10.1007/bf00225192 · Cited by 68
Metadata
- Authors
- Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., & MacDonald, M.
- Affiliations
- Massachusetts General Hospital (US)
- Boston University (US)
- University of Rome Tor Vergata (IT)
- Johns Hopkins University (US)
- Indiana University (US)
- University of Rochester Medicine (US)
- Rutgers, The State University of New Jersey (US)
- Emory University (US)
- Harvard University (US)
- Universidad del Zulia (VE)
- Long Island Jewish Medical Center (US)
- Kennedy Krieger Institute (US)
- Hospital Virgen del Camino (ES)
- University of Mississippi Medical Center (US)
- Hereditary Disease Foundation (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1993-08
- Volume
- 4
- Issue
- 4
- Pages
- 387-392
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1994285647
- Cited by
- 1,089
- References
- 35
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 37 · 2023: 23 · 2022: 39 · 2021: 42 · 2020: 36 · 2019: 38 · 2018: 35 · 2017: 42 · 2016: 26 · 2015: 35 · 2014: 31 · 2013: 39 · 2012: 47
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns017978-06)
- National Institute of Neurological Disorders and Stroke (NS17978, NS16375, NS 16367)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Huntington's disease, trinucleotide repeat expansion, repeat instability, age of onset, paternal transmission, spermatogenesis, presymptomatic diagnosis, repeat length
- MeSH terms
- Adult, Age Factors, Female, Genetic Carrier Screening, Humans, Huntington Disease, Genetic Linkage, Male, Middle Aged, Pedigree, Repetitive Sequences, Nucleic Acid, Spermatozoa, Linkage Disequilibrium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review